Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Brand
Brand / product

STIVANT

Bevacizumab · 400 mg/16 mL

ShareSend this page
Official DRAP price PKR 102,238.25 1's
PKR 102,238.25 / vial/unit
✓ DRAP listed · Verified 2026-08-08
Unit-price intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unit
Lowest unit pricePKR 102,238.25/ vial/unit
Highest unit pricePKR 236,486.52/ vial/unit
Unit-price rangePKR 102,238.25–236,486.52/ vial/unit
Comparable alternatives2current-price listings
This brandPKR 102,238.25 / vial/unit
Lowest-priced equivalent
Low
High
Compare equivalent brands 3 comparable presentations
BrandCompanyPackOfficial pack priceUnit price
STIVANT This brand CCL Pharmaceuticals (Pvt.) Ltd. 1's PKR 102,238.25 PKR 102,238.25/ vial/unit
Cizumab The Searle Company Limited 1's PKR 132,267.99 PKR 132,267.99/ vial/unit
Avastin Roche Pakistan Ltd 1's PKR 236,486.52 PKR 236,486.52/ vial/unit

Comparison is calculated from current listed prices and normalized pack quantities. Products with a different strength, dosage form, or incompatible/ambiguous pack unit are excluded.

Product details

Generic
Bevacizumab
Therapeutic area
Oncology & immunology
Drug class
Antineoplastic medicines
ATC
Strength
400 mg/16 mL
Dosage form
Concentrate for solution for infusion
Pack
1's
Registration no.
107906
Verification
2026-08-08

Manufacturer

CCL Pharmaceuticals (Pvt.) Ltd.

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 102,238.252026-07-232026-08-08DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.